<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Donovan Nordentoft | Activity</title>
	<link>https://recash.wpsoul.net/members/maplebox86/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/maplebox86/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Donovan Nordentoft.</description>
	<lastBuildDate>Wed, 29 Jul 2026 13:58:55 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a6d0936379f99252bb53128bbba23c60</guid>
				<title>Donovan Nordentoft posted an update: Second-line treatment for immune thrombocytopenia (ITP) is [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/142428/</link>
				<pubDate>Sat, 04 Jan 2025 09:45:18 +0000</pubDate>

									<content:encoded><![CDATA[<p>Second-line treatment for immune thrombocytopenia (ITP) is not well reported for patients treated in real-world clinical settings.</p>
<p> The purpose of this study was to compare outcomes of four second-line treatments for ITP.</p>
<p> Included adult patients had at least two medical records containing ITP diagnoses and second-line eltrombopag,&hellip;<span class="activity-read-more" id="activity-read-more-142428"><a href="https://recash.wpsoul.net/activity/p/142428/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ed8bf591f4685cdc63dd542b5cb53753</guid>
				<title>Donovan Nordentoft posted an update: For patients, the reactions to the tools were more positive. [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/133736/</link>
				<pubDate>Wed, 01 Jan 2025 09:44:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>For patients, the reactions to the tools were more positive. Patients valued written information and a signed agreement to delay the test. However, patients expressed that a strong desire for diagnostic imaging would likely over-ride any effect of written advice to delay the test. The term &#8216;false alarm&#8217; to describe overdiagnosis was poorly&hellip;<span class="activity-read-more" id="activity-read-more-133736"><a href="https://recash.wpsoul.net/activity/p/133736/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">95a5aba01ea69eb77e8255ef689b45d1</guid>
				<title>Donovan Nordentoft posted an update: SLE/CYC+ women had a greater prevalence of AMH &#060;1.0 ng/mL c [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/127930/</link>
				<pubDate>Mon, 30 Dec 2024 09:55:38 +0000</pubDate>

									<content:encoded><![CDATA[<p>SLE/CYC+ women had a greater prevalence of AMH &lt;1.0 ng/mL compared with women without SLE (prevalence ratio (PR) 2.90, 95% CI 1.29 to 6.51). SLE/CYC- women were also slightly more likely to have AMH &lt;1.0 ng/mL (PR 1.62, 95% CI 0.93 to 2.82) than comparison women. Results were similar when considering AMH &lt;25th percentile by age of comparison women&hellip;<span class="activity-read-more" id="activity-read-more-127930"><a href="https://recash.wpsoul.net/activity/p/127930/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">706c5f27705d94fc5ff385095a174321</guid>
				<title>Donovan Nordentoft became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/92772/</link>
				<pubDate>Fri, 20 Dec 2024 12:51:54 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>